Buscar
Mostrando ítems 1-10 de 11
Artículo
Atención farmacéutica sin fronteras
(Elsevier, 2023-09)
Artículo
Evaluation of patient experience with a model of coordinated telematic pharmaceutical care between hospital and rural pharmacies in Spain: a proof of concept
(Taylor and Francis Group, 2023-04-14)
Purpose: To determine the usefulness of a coordinated pharmaceutical care model between the specialized hospital setting and the rural community care setting, based on the incorporation of telepharmacy based on ...
Artículo
Análisis 2016-2021 del desarrollo del Proyecto de atención farmacéutica al paciente externo MAPEX por Comunidades Autónomas en España
(Elsevier, 2024-03)
Objetivo: analizar la evolución del proyecto «Mapa Estratégico de Atención Farmacéutica al Paciente Externo» (MAPEX) por comunidades autónomas en España, a través del análisis de los resultados de la encuesta de situación ...
Artículo
Actualización 2022 de los indicadores para la calidad asistencial y la atención farmacéutica a las personas que viven con el virus de la inmunodeficiencia humana
(Elsevier, 2023-06)
Objetivo actualizar y definir los indicadores para la mejora de la calidad asistencial y la atención farmacéutica a las personas que viven con infección por VIH en España. Método el presente proyecto, que actualiza ...
Artículo
Similar incidence of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy
(Public Library of Science, 2021)
Background Hydroxychloroquine is not efficacious as post-exposure prophylaxis against coronavirus disease 2019 (COVID-19). It is not known whether as pre-exposure prophylaxis it may prevent COVID-19. Objective To compare ...
Artículo
Patient experience evaluation of the CMO-based pharmaceutical care model vs usual care in people living with HIV
(Dove Medical Press Ltd, 2022)
Objective: To compare patient experience in a real-life population of people living with HIV (PLWH) who received pharmaceutical care (PC) based on the Capacity-Motivation-Opportunity (CMO) model versus the traditional ...
Artículo
Application of CMO (capacity, motivation, and opportunity) methodology in pharmaceutical care to optimize the pharmacotherapy in older people living with HIV. DISPIMDINAC project.
(Sociedad Española de Quimioterapia, 2023-09-19)
Objective. To determine the effectiveness of a pharmaceutical intervention, based on the CMO methodology (capacity, motivation and opportunity), to decrease the prevalence of the PIMDINAC concept (potentially inappropriate ...
Artículo
Drug–drug interactions between treatment specific pharmacotherapy and concomitant medication in patients with COVID-19 in the first wave in Spain
(NATURE PUBLISHING GROUP, 2021)
Primary aim was to assess prevalence and severity of potential and real drug–drug interactions (DDIs) among therapies for COVID‑19 and concomitant medications in hospitalized patients with confirmed SARS‑CoV‑2 infection. ...
Artículo
Potential interactions between pangenotypic direct-acting antivirals and concomitant cardiovascular therapies in patients with chronic hepatitis C virus infection
(SAGE Publications, 2020)
To identify potential drug interactions (DIs) between pangenotypic direct-acting antivirals (pDAAs) and concomitant cardiovascular (CV) therapies in patients with chronic hepatitis C (CHC).
Artículo
Outpatients’ Opinion And Experience Regarding Telepharmacy During The COVID-19 Pandemic: The Enopex Project
(Taylor and Francis Group, 2021)
Background: Telepharmacy, as a remote pharmaceutical care procedure, is being used worldwide during the COVID-19 pandemic, with the aim of preserving the health of patients and professionals. Its future development should ...